Hisami Fukuda - Concepedia

Author

Hisami Fukuda

Also Known As

H. Fukuda, Hisami Fukuda

Publications

428

Citations

H-Index

Concepts

All Affiliations

Hisami Fukuda is an author at Akita University specializing in oncology, medicine, and cancer research.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	23
2	Health Sciences	1	1	10
3	Pharmacology	1	1	13
4	Radiation Medicine	1	1	10
5	Cancer Therapeutics	1	1	10

Hisami Fukuda

Publications

422

Citations

H-Index

Page 1

	Year	Citations
A Phase II Trial of Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma: Japan Clinical Oncology Group Study (JCOG9708) Hoichi Kato, Akihiro Sato, Hisami Fukuda, Japanese Journal of Clinical Oncology	2009	291
Impact of<i>IGF-I</i>and<i>CYP19</i>Gene Polymorphisms on the Survival of Patients With Metastatic Prostate Cancer Norihiko Tsuchiya, Lizhong Wang, Hiroyoshi Suzuki, Journal of Clinical Oncology	2006	75
Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer Tomonori Habuchi, Osamu Ogawa, Shigeru Satoh, Oncology Reports	2007	33
Effect of Levofloxacin on the Efficacy and Adverse Events in Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer: Results of a Randomized, Prospective, Multicenter Study Kazuyuki Numakura, Mizuki Kobayashi, Toshiya Ishida, European Urology Focus Adverse EventsUrologyUrological ResearchGenitourinary CancerMedicine	2022	13
A multicenter randomized phase II (rPII)/III study comparing concurrent chemoradiotherapy (CRT) with low-dose cisplatin plus continuous infusion of 5-fluorouracil (LDPF) and standard-dose PF (SDPF) for locally advanced unresectable squamous cell carcinoma of the thoracic esophagus (JCOG0303). M. Shinoda, N Ando, Hidenori Kato, Journal of Clinical Oncology Esophageal CancerCisplatin-based CrtLdpf GroupLow-dose CisplatinRadiation Medicine	2010	10

Page 1